Literature DB >> 2752808

Determinants of maximum exercise capacity in patients with chronic airflow obstruction.

T A Dillard1, S Piantadosi, K R Rajagopal.   

Abstract

Patients with chronic airflow obstruction (CAO) often develop impairment of respiratory muscle function. We hypothesized that inspiratory muscle strength, as assessed by resting, peak inspiratory pressure (PIP) may be an important determinant of maximum exercise capacity in patients with CAO. Twenty ambulatory male patients (mean age, 56 +/- 3 years [+/- SE]) with CAO (FEV1, 1.72 +/- 0.21 L) comprised the studied population. Oxygen consumption at incremental cycle ergometry to tolerance (VO2max, 1.80 +/- 0.20 L/min) served as the dependent variable for regression vs measures of resting pulmonary function. Significant correlations with VO2max included power output in watts (r = 0.951), VEmax (r = 0.858), Dsb (r = 0.841), PIP (r = 0.816), age (r = -0.809), FEV1 (r = 0.763), and FVC (r = 0.663). The FEV1, Dsb, and PIP each entered into a multiple linear regression relationship describing VO2max. Also, when paired with VEmax as independent variables in multiple regression, PIP and Dsb each improved description of VO2max over VEmax alone (p less than 0.05), whereas FEV1 and FVC did not (p greater than 0.05). We conclude that factors other than ventilatory capacity also have a quantitative effect on VO2max and that PIP constitutes a determinant of maximum exercise capacity in patients with CAO.

Entities:  

Mesh:

Year:  1989        PMID: 2752808     DOI: 10.1378/chest.96.2.267

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.

Authors:  A Ikeda; K Nishimura; H Koyama; M Tsukino; M Mishima; T Izumi
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

2.  Chronic obstructive pulmonary disease phenotypes: the future of COPD.

Authors:  MeiLan K Han; Alvar Agusti; Peter M Calverley; Bartolome R Celli; Gerard Criner; Jeffrey L Curtis; Leonardo M Fabbri; Jonathan G Goldin; Paul W Jones; William Macnee; Barry J Make; Klaus F Rabe; Stephen I Rennard; Frank C Sciurba; Edwin K Silverman; Jørgen Vestbo; George R Washko; Emiel F M Wouters; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2010-06-03       Impact factor: 21.405

Review 3.  Systematic Review of the Association Between Laboratory- and Field-Based Exercise Tests and Lung Function in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Martin Bell; Iain Fotheringham; Yogesh Suresh Punekar; John H Riley; Sarah Cockle; Sally J Singh
Journal:  Chronic Obstr Pulm Dis       Date:  2015-07-08

4.  A Study of Patients with "Interface Respiratory Failure" Due to Chronic Obstructive Pulmonary Diseases.

Authors:  Y Wang; J Zhang; J Feng; J Cao; B-Y Chen
Journal:  West Indian Med J       Date:  2015-01-22       Impact factor: 0.171

Review 5.  Performing a lung disability evaluation: how, when, and why?

Authors:  Akshay Sood
Journal:  J Occup Environ Med       Date:  2014-10       Impact factor: 2.162

6.  Cardiovascular and respiratory dysfunction in chronic obstructive pulmonary disease complicated by impaired peripheral oxygenation.

Authors:  Ming-Lung Chuang; Shih-Feng Huang; Chun-Hung Su
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-02-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.